# First Carolina Financial Services, Inc.: financial statements, quarterly

FCBM · NYSE · CIK 1531193 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fcbm.md) · [Financials](/companies/fcbm/financials.md) · [Filings](/companies/fcbm/filings.md) · [Insiders](/companies/fcbm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fcbm/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-06-30) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: |
| Revenue | $m | [12.1](/filings/0001628280-26-056931.md) | [5.5](/filings/0001628280-26-056931.md) |
| Income tax | $m | [1.6](/filings/0001628280-26-056931.md) | [1.4](/filings/0001628280-26-056931.md) |
| Net income | $m | [4.6](/filings/0001628280-26-056931.md) | [5.1](/filings/0001628280-26-056931.md) |
| Diluted EPS | $ per share | [0.18](/filings/0001628280-26-056931.md) | [0.20](/filings/0001628280-26-056931.md) |
| Basic EPS | $ per share | [0.18](/filings/0001628280-26-056931.md) | [0.21](/filings/0001628280-26-056931.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2025-12-31) | period not labelled (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | [134](/filings/0001628280-26-056931.md) | not reported | [119](/filings/0001628280-26-056931.md) |
| Total assets | $m | not reported | not reported | [3,386](/filings/0001628280-26-056931.md) | [3,318](/filings/0001628280-26-056931.md) | not reported | [3,406](/filings/0001628280-26-056931.md) |
| Total liabilities | $m | not reported | not reported | not reported | [2,971](/filings/0001628280-26-056931.md) | not reported | [2,976](/filings/0001628280-26-056931.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | [75.0](/filings/0001628280-26-056931.md) | not reported | [50.0](/filings/0001628280-26-056931.md) |
| Shareholders' equity | $m | [337](/filings/0001628280-26-056931.md) | [343](/filings/0001628280-26-056931.md) | [350](/filings/0001628280-26-056931.md) | [347](/filings/0001628280-26-056931.md) | [353](/filings/0001628280-26-056931.md) | [430](/filings/0001628280-26-056931.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Shares

| Line item | Unit | period not labelled (2025-06-30) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [25.0](/filings/0001628280-26-056931.md) | [25.2](/filings/0001628280-26-056931.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 31,068,852 at 2026-08-12, from the cover of the [10-Q filed 2026-08-14](/filings/0001628280-26-056931.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.